BAT/FF 300/100 (n = 42) | Placebo (n = 20) | |
---|---|---|
Trough FEV1 at Day 42, La | n = 42 | n = 20 |
LS mean change (SE) | 0.24 (0.03) | −0.02 (0.04) |
Difference vs. placebo (95% CI) | 0.26 (0.17, 0.36) | – |
Rescue medication use Weeks 1–6, number of occasions/dayb | n = 37 | n = 16 |
LS mean change (SE) | −0.50 (0.15) | −0.33 (0.24) |
Difference vs. placebo (95% CI) | −0.17 (− 0.75, 0.42) | – |
CAT score at Day 42b | n = 35 | n = 18 |
LS mean change (SE) | −1.86 (0.78) | −0.11 (1.14) |
Difference vs. placebo (95% CI) | −1.75 (−4.54, 1.04) | – |
SGRQ score at Day 42b | n = 34 | n = 18 |
LS mean change (SE) | −3.13 (1.79) | −1.48 (2.62) |
Difference vs. placebo (95% CI) | −1.65 (− 8.13, 4.84) | – |